Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Clinical Diagnosis: Sarcoma/Melanoma

  • You have access
    Assessment of early response to neoadjuvant chemotherapy in osteosarcoma using parallely installed PET/CT-MRI: Prospective study
    Eun Young Park, Ilhan Lim, Byung Il Kim, Jae-Soo Koh, Chang-Bae Kong, Soo Yong Lee, Chang Woon Choi and Sang Moo Lim
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1920;
  • You have access
    FDG PET/CT of patients with melanoma: Clinical impact of imaging the lower extremities
    Tejvir Bawa, Aaron Jessop, Eric Rohren and Dominique Delbeke
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1918;
  • You have access
    Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?
    Franziska Walter, Noah Federman, Wipapat Apichairuk, Michael Phelps and Johannes Czernin
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1919;
  • You have access
    Metabolic activity measured on PET CT correlates with clinical outcomes in patients with limb and girdle sarcomas
    Sonia Skamene, David Roberge, Robert Turcotte, Rajan Rakheja, Mathieu Charest, Marc Hickeson and Carolyn Freeman
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 593;
  • You have access
    A prospective open label phase 3 trial of receptor-targeted 99mTc-tilmanocept for sentinel node evaluation in breast cancer and melanoma
    Vernon Sondak and Anne Wallace
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 599;
  • You have access
    Metabolic response by FDG-PET correlates with exon11 KIT mutation in patients with mucosal or acral melanoma or melanoma arising on chronically sun damaged skin treated with imatinib in a phase II trial
    K. Zukotynski, Jeffrey Yap, Anita Giobbie-Hurder, Jeffrey Weber, R. Gonzalez, T. Gajewski, Steven O'Day, Kevin Kim, S. Hodi and Annick Van Den Abbeele
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 597;
  • You have access
    Liver and mediastinum SUV in F-18 FDG PET/CT: Impact of immunotherapy
    Abdullah Almardoof, Mustafa Altinyay, Waseem Touma, Nghi Nguyen and Medhat Osman
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 598;
  • You have access
    The role of F-18 FDG PET/CT to predict prognosis of patients with osteosarcoma
    Joon Yeun Park, Ilhan Lim, Chang-Bae Kong, Won Seok Song, Wan hyeong Cho, Dae Geun Jeon, Soo Yong Lee, Byung Il Kim, Chang Woon Choi and Sang Moo Lim
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 594;
  • You have access
    Thallium-201 scintigraphy for evaluation of long-term prognosis in patients with osteosarcoma
    Anri Inaki, Hiroshi Wakabayashi, Junichi Taki, Hisashi Sumiya, Hiroyuki Tsuchiya and Seigo Kinuya
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 596;
  • You have access
    Metabolic activity measured by SUV from FDG-PET scans as a predictor of histopathologic characteristics: A retrospective review of 136 patients with sarcoma
    Rajan Rakheja, Ayoub Nahal, Mathieu Charest, Fadi Brimo, Sonia Skamene, Laurent Azoulay, Jonathan Assayag and Marc Hickeson
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 595;
SNMMI

© 2025 SNMMI

Powered by HighWire